These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 14757427

  • 41. Lack of enterocyte iron accumulation in the ferroportin disease.
    Corradini E, Montosi G, Ferrara F, Caleffi A, Pignatti E, Barelli S, Garuti C, Pietrangelo A.
    Blood Cells Mol Dis; 2005; 35(3):315-8. PubMed ID: 16135412
    [Abstract] [Full Text] [Related]

  • 42. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3).
    Cazzola M, Cremonesi L, Papaioannou M, Soriani N, Kioumi A, Charalambidou A, Paroni R, Romtsou K, Levi S, Ferrari M, Arosio P, Christakis J.
    Br J Haematol; 2002 Nov; 119(2):539-46. PubMed ID: 12406098
    [Abstract] [Full Text] [Related]

  • 43. Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload.
    Pelucchi S, Mariani R, Salvioni A, Bonfadini S, Riva A, Bertola F, Trombini P, Piperno A.
    Clin Genet; 2008 Feb; 73(2):171-8. PubMed ID: 18177470
    [Abstract] [Full Text] [Related]

  • 44. A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation.
    Adams PC, Barton JC.
    J Hepatol; 2011 Aug; 55(2):453-8. PubMed ID: 21354228
    [Abstract] [Full Text] [Related]

  • 45. [Hereditary and acquired iron overload].
    de Korwin JD.
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [Abstract] [Full Text] [Related]

  • 46. Autosomal dominant hereditary hemochromatosis associated with two novel Ferroportin 1 mutations in Spain.
    Bach V, Remacha A, Altés A, Barceló MJ, Molina MA, Baiget M.
    Blood Cells Mol Dis; 2006 Nov; 36(1):41-5. PubMed ID: 16257244
    [Abstract] [Full Text] [Related]

  • 47. [Management of iron overload during pregnancy and childbirth in a patient with ferroportin disease].
    Ohara K, Tsuge N, Watanabe S, Eda H, Ogasawara F, Kondo T, Yoshida S, Kojima K.
    Rinsho Ketsueki; 2023 Nov; 64(11):1410-1414. PubMed ID: 38072426
    [Abstract] [Full Text] [Related]

  • 48. Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease.
    Viveiros A, Panzer M, Baumgartner N, Schaefer B, Finkenstedt A, Henninger B, Theurl I, Nachbaur K, Weiss G, Haubner R, Decristoforo C, Tilg H, Zoller H.
    Liver Int; 2020 Aug; 40(8):1941-1951. PubMed ID: 32450003
    [Abstract] [Full Text] [Related]

  • 49. Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload.
    Jouanolle AM, Douabin-Gicquel V, Halimi C, Loréal O, Fergelot P, Delacour T, de Lajarte-Thirouard AS, Turlin B, Le Gall JY, Cadet E, Rochette J, David V, Brissot P.
    J Hepatol; 2003 Aug; 39(2):286-9. PubMed ID: 12873829
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. SLC40A1-R178G mutation and ferroportin disease.
    Speletas M, Onoufriadis E, Kioumi A, Germenis AE.
    J Hepatol; 2011 Sep; 55(3):730-731. PubMed ID: 21320560
    [No Abstract] [Full Text] [Related]

  • 53. Inherited iron loading: genetic testing in diagnosis and management.
    Worwood M.
    Blood Rev; 2005 Mar; 19(2):69-88. PubMed ID: 15603911
    [Abstract] [Full Text] [Related]

  • 54. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ, Mayr R, McFarlane I, Hermann M, Halsall DJ, Zoller H, Cox TM.
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [Abstract] [Full Text] [Related]

  • 55. A 10-year Follow-up Study of a Japanese Family with Ferroportin Disease A: Mild Iron Overload with Mild Hyperferritinemia Co-occurring with Hyperhepcidinemia May Be Benign.
    Hayashi H, Yano M, Urawa N, Mizutani A, Hamaoka S, Araki J, Kojima Y, Naito Y, Kato A, Tatsumi Y, Kato K.
    Intern Med; 2018 Oct 01; 57(19):2865-2871. PubMed ID: 29780118
    [Abstract] [Full Text] [Related]

  • 56. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis.
    Majore S, Bonaccorsi di Patti MC, Valiante M, Polticelli F, Cortese A, Di Bartolomeo S, De Bernardo C, De Muro M, Faienza F, Radio FC, Grammatico P, Musci G.
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb 01; 1864(2):464-470. PubMed ID: 29154924
    [Abstract] [Full Text] [Related]

  • 57. Genetic disorders affecting proteins of iron and copper metabolism: clinical implications.
    Miyajima H.
    Intern Med; 2002 Oct 01; 41(10):762-9. PubMed ID: 12412992
    [Abstract] [Full Text] [Related]

  • 58. A novel mutation in ferroportin implicated in iron overload.
    Wallace DF, Dixon JL, Ramm GA, Anderson GJ, Powell LW, Subramaniam VN.
    J Hepatol; 2007 May 01; 46(5):921-6. PubMed ID: 17383046
    [Abstract] [Full Text] [Related]

  • 59. A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis.
    Morris TJ, Litvinova MM, Ralston D, Mattman A, Holmes D, Lockitch G.
    Blood Cells Mol Dis; 2005 May 01; 35(3):309-14. PubMed ID: 16111902
    [Abstract] [Full Text] [Related]

  • 60. Non-HFE haemochromatosis.
    Wallace DF, Subramaniam VN.
    World J Gastroenterol; 2007 Sep 21; 13(35):4690-8. PubMed ID: 17729390
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.